Cordis

CompanyUnited StatesFounded 1957

Wikidata

Cordis develops one asset, in phase 3 (SELUTION SLR SUSTANE in superficial femoral artery disease). Mostly device; based in the United States, founded in 1957.

1
Asset
Furthest stage
Phase 3
1
Trial
0
Signals

Pipeline

1
  • SELUTION SLR SUSTANE

    Drug-eluting balloon delivering sirolimus to maintain arterial patency in peripheral artery intervention

    Phase 3, Device, superficial femoral artery disease

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials3
  • Similar companies1

Intelligence